PlainRecalls
FDA Drug Moderate Class II Terminated

Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534

Reported: October 14, 2020 Initiated: January 15, 2020 #D-0016-2021

Product Description

Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Details

Recalling Firm
Direct Rx
Units Affected
a) 54 bottles; b) 26 bottles
Distribution
FL, GA
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534. Recalled by Direct Rx. Units affected: a) 54 bottles; b) 26 bottles.
Why was this product recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 14, 2020. Severity: Moderate. Recall number: D-0016-2021.